KPV

Why Researchers Choose KPV

KPV is the anti-inflammatory C-terminal tripeptide of alpha-MSH, valued in research because it concentrates most of the parent hormone’s NF-kB suppressing activity into a small, stable three-amino-acid molecule. The KPV 10mg vial is studied across three main areas:

Inflammatory Bowel Disease: Across murine colitis models, KPV lowers intestinal inflammation, helps preserve epithelial barrier integrity, and reduces disease activity scores. Oral, gut-targeted dosing tends to show the strongest signal for colonic disease.

Skin Inflammation and Wound Healing: KPV dampens keratinocyte inflammatory responses and has been investigated in psoriasis models, re-epithelialisation, and irritant contact dermatitis.

Neuroinflammation: Its blood-brain barrier penetration has opened research into central applications, including suppression of microglial activation.

Stacking Considerations

• With BPC-157: complementary gut coverage, where BPC-157 drives mucosal repair and angiogenesis while KPV suppresses the surrounding inflammatory environment
• With LL-37: antimicrobial action alongside KPV’s anti-inflammatory signal for infection-associated gut or skin models
• With VIP: both quieten NF-kB through distinct pathways, and VIP adds direct effects on gut motility and secretion

Reconstitution and Storage

Reconstitution: use bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: keep refrigerated at 2-8°C, protect from light.

For research purposes only. Not for human consumption.